期刊文献+

糖尿病与肝病的研究进展 被引量:12

Current researches of liver disease in diabetes mellitus
下载PDF
导出
摘要 在我国,糖尿病的发病率逐年上升。肝脏在糖尿病发生的病理生理过程中占重要位置。除了糖尿病并发的心血管病变、肾病、眼科疾病外,肝脏相关的并发症也较常见,临床上常难以辨别。尤其我国是肝病的高发地区。这里仅就糖尿病的相关肝病:主要为非酒精性脂肪性肝病和丙型肝炎,以及肝硬化、急性肝衰竭、肝癌等作一综述。 Diabetes mellitus is a growing health concern in our country. The liver has a key role in the pathophysiologic processes of diabetes. In addition to the well-known cardiovascular, renal, and ophthalmologic complications of diabetes, liverrelated complications occur commonly and are often underrecognized, especially liver diseases occur more often in our country. The ensuing article will review the relationship between diabetes mellitus and two common liver diseases: chronic hepatitis C and nonalcoholic fatty liver disease. The association with diabetes and cirrhosis, acute liver failure and hepatocellular carcinoma will also be discussed.
作者 吴柳 范竹萍
出处 《国际消化病杂志》 CAS 2008年第4期326-329,共4页 International Journal of Digestive Diseases
关键词 糖尿病 非酒精性脂肪性肝病 肝硬化 急性肝衰竭 肝癌 丙型肝炎 Diabetes mellitus Nonalcoholic fatty liver disease (NAFLD) Liver cirrhosis Acute liver failure Hepatocellular carcinoma Hepatitis C virus(HCV)
  • 相关文献

参考文献23

  • 1de Marco R, Locatelli F, Zoppini G, et al. Cause-specific mor tality in type2 diabetes: the Verona diabetes study. Diabetes Care, 1999,22:756-761.
  • 2El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology, 2004,126: 460-468.
  • 3Younossi ZM, Gramlich T, Matteoni CA, et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes, Clin Gastroenteroi Hepatoi, 2004,2 : 262-265.
  • 4Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med, 1999,107:450-455.
  • 5Kim JK, Fillmore JJ, Sunshine MJ, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest, 2004,114: 823-827.
  • 6Feldstein AE, Werneburg NW, Canbay A, et al. Free farty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway. Hepatology, 2004,40:185-194.
  • 7Leclercq IA, Farrell GC, Field J, et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest, 2000, 105 : 1067-1075.
  • 8Perez-Carreras M, Del Hoyo P, Martin MA, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology, 2003,38 : 999-1007.
  • 9George J, Pera N, Phung N, et al. Lipid peroxidation, stellate cell activation and hepaticfibrogenesis in a rat model of chronic steatohepatitis. J Hepatol, 2003, 39: 756-764.
  • 10Walsh MJ, Vanags DM, Clouston AD, et al. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology, 2004, 39: 1230-1238.

同被引文献89

引证文献12

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部